Cited by 1,062Immune Response and InflammationImmunotherapy and Immune Responsesinterferon and immune responses

The DOI matches its Crossref record; 61 of the 63 references it cites were found in a registry or an index.

mRNA Is an Endogenous Ligand for Toll-like Receptor 3

Open access

Karikó, Katalin, Ni, Houping, Capodici, John, Lamphier, Marc, Weissman, Drew·2004·Journal of Biological Chemistry

Open this paper in CoChat — free account

Abstract

Toll-like receptors (TLRs) are the basic signaling receptors of the innate immune system. They are activated by molecules associated with pathogens or injured host cells and tissue. TLR3 has been shown to respond to double stranded (ds) RNA, a replication intermediary for many viruses. Here we present evidence that heterologous RNA released from or associated with necrotic cells or generated by in vitro transcription also stimulates TLR3 and induces immune activation. To assess RNA-mediated TLR3 activation, human embryonic kidney 293 cells stably expressing TLR3 and containing a nuclear factor-kappaB-dependent luciferase reporter were generated. Exposing these cells to in vitro transcribed RNA resulted in a TLR3-dependent induction of luciferase activity and interleukin-8 secretion. Treatment with in vitro transcribed mRNA activated nuclear factor-kappaB via TLR3 through a process that was dose-dependent and involved tyrosine phosphorylation. Furthermore, in vitro transcribed natural or 2'-fluoro-substituted mRNA induced the expression of TLR3, interferon regulatory factor-1, tumor necrosis factor-alpha, and interleukin-1 receptor-associated kinase-M mRNA in human dendritic cells (DCs). DCs responded to mRNA treatment by expressing activation markers, and this maturation was inhibited by antagonistic TLR3-specific antibody. Endogenous RNA released from or associated with necrotic cells also stimulated DCs, leading to interferon-alpha secretion, which could be abolished by pretreatment of necrotic cells with RNase. These results demonstrate that RNA, likely through secondary structure, is a potent host-derived activator of TLR3. This finding has potential physiologic relevance because RNA escaping from damaged tissue or contained within endocytosed cells could serve as an endogenous ligand for TLR3 that induces or otherwise modulates immune responses.

Integrity signals

Registry

Crossref · 10.1074/jbc.m310175200

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Mfold web server for nucleic acid folding and hybridization prediction
Zuker, M. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg595 · Cited by 13,404
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
Tolerance, Danger, and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,848
Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information
Zuker, M., & Stiegler, P. (1981) · Nucleic Acids Research · doi:10.1093/nar/9.1.133 · Cited by 3,604
Three-dimensional tracking of axonal projections in the brain by magnetic resonance imaging
Mori, S., Crain, B. J., Chacko, V. P., & van Zijl, P. C. M. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199902)45:2 · Cited by 3,513
Subsets of Human Dendritic Cell Precursors Express Different Toll-like Receptors and Respond to Different Microbial Antigens
Kadowaki, N., Ho, S., Antonenko, S., de Waal Malefyt, R., Kastelein, R. A., Bazan, F., & Liu, Y.-J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.863 · Cited by 1,964
Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette-Zlatanova, B. C., Shlomchik, M. J., & Marshak‐Rothstein, A. (2002) · Nature · doi:10.1038/416603a · Cited by 1,929
IRF Family of Transcription Factors as Regulators of Host Defense
Taniguchi, T., Ogasawara, K., Takaoka, A., & Tanaka, N. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.623 · Cited by 1,658
Oligosaccharides of Hyaluronan Activate Dendritic Cells via Toll-like Receptor 4
Termeer, C., Benedix, F., Sleeman, J., Fieber, C., Voith, U., Ahrens, T., Miyake, K., Freudenberg, M., Galanos, C., & Simon, J. C. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20001858 · Cited by 1,378
Cd8+ but Not Cd8− Dendritic Cells Cross-Prime Cytotoxic T Cells in Vivo
den Haan, J. M. M., Lehar, S. M., & Bevan, M. J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.12.1685 · Cited by 1,319

Flagged first, then by citations

Show all 63 references

2 of the 63 references couldn’t be matched to a known paper.

Research works printed but not linked: 8

Armant, 2002, Genome Biol.
Barton, 2002, Curr. Top. Microbiol. Immunol., 270, 81
Vabulas, 2002, Curr. Top. Microbiol. Immunol., 270, 169
Grentzmann, 1998, RNA (N. Y.), 4, 479
Williams, 2001, Science's STKE
Kirschning, 2002, Curr. Top. Microbiol. Immunol., 270, 121
Larsson, 2003, Curr. Top. Microbiol. Immunol., 276, 261
Belz, 2002, Crit. Rev. Immunol., 22, 439

Sorted by citations

Items 301–400 of 1,000

Nucleic Acid Sensors and Programmed Cell Death
Maelfait, J., Liverpool, L., & Rehwinkel, J. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.11.016 · Cited by 85
mRNA in cancer immunotherapy: beyond a source of antigen
Hoecke, L. V., Verbeke, R., Dewitte, H., Lentacker, I., Vermaelen, K. Y., Breckpot, K., & Lint, S. V. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01329-3 · Cited by 85
Lipid Nanoparticle Delivery Systems to Enable mRNA-Based Therapeutics
Semple, S. C., Leone, R. D., Barbosa, C., Tam, Y. K., & Lin, P. J. C. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020398 · Cited by 80
Activation of Dendritic Cells by Toll-Like Receptors and C-Type Lectins
Diebold, S. S. (2008) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-71029-5_1 · Cited by 84
Cooperative molecular and cellular networks regulate Toll‐like receptor‐dependent inflammatory responses
Morris, G. E., Parker, L. C., Ward, J. R., Jones, E. C., Whyte, M. K. B., Brightling, C. E., Bradding, P., Dower, S., & Sabroe, I. (2006) · The FASEB Journal · doi:10.1096/fj.06-5910fje · Cited by 80
Lung CD8+ T cells in COPD have increased expression of bacterial TLRs
Freeman, C. M., Martínez, F. J., Han, M. K., Washko, G. R., McCubbrey, A. L., Chensue, S. W., Arenberg, D. A., Meldrum, C. A., McCloskey, L., & Curtis, J. L. (2013) · Respiratory Research · doi:10.1186/1465-9921-14-13 · Cited by 85
The role of toll-like receptors in systemic lupus erythematosus
Rahman, A. H., & Eisenberg, R. A. (2006) · Springer Seminars in Immunopathology · doi:10.1007/s00281-006-0034-3 · Cited by 79
Acute Brain Injury Triggers MyD88-Dependent, TLR2/4-Independent Inflammatory Responses
Koedel, U., Merbt, U. M., Schmidt, C., Angele, B., Popp, B., Wagner, H., Pfister, H.-W., & Kirschning, C. J. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060821 · Cited by 78
Examining the evidence for extracellular RNA function in mammals
Gruner, H. N., & McManus, M. T. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-021-00346-8 · Cited by 78
Toll-Like Receptors and Myocardial Inflammation
Feng, Y., & Chao, W. (2011) · International Journal of Inflammation · doi:10.4061/2011/170352 · Cited by 83
Toll-Like Receptor 2 Contributes to Chemokine Gene Expression and Macrophage Infiltration in the Dorsal Root Ganglia after Peripheral Nerve Injury
Kim, D., You, B., Lim, H., & Lee, S. J. (2011) · Molecular Pain · doi:10.1186/1744-8069-7-74 · Cited by 81
Regulation of Toll-like receptor 1 and -2 in neonatal mice brains after hypoxia-ischemia
Stridh, L., Smith, P. L. P., Naylor, A. S., Wang, X., & Mallard, C. E. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-45 · Cited by 78
Deleterious Role of TLR3 during Hyperoxia-induced Acute Lung Injury
Murray, L. A., Knight, D. A., McAlonan, L., Argentieri, R. L., Joshi, A., Shaheen, F., Cunningham, M., Alexopolou, L., Flavell, R. A., Sarisky, R. T., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200807-1020oc · Cited by 79
Role of TLR2‐dependent inflammation in metastatic progression
Kim, S.-H., & Karin, M. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05882.x · Cited by 78
Pathogenic anti-DNA antibodies modulate gene expression in mesangial cells: Involvement of HMGB1 in anti-DNA antibody-induced renal injury
Qing, X., Pitashny, M., Thomas, D. B., Barrat, F. J., Hogarth, P. M., & Putterman, C. (2008) · Immunology Letters · doi:10.1016/j.imlet.2008.08.007 · Cited by 77
Toll-like receptors and their role in carcinogenesis and anti-tumor treatment
Wolska, A., Lech‐Marańda, E., & Robak, T. (2008) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-008-0048-z · Cited by 77
Toll-like receptor 3 signalling mediates angiogenic response upon shock wave treatment of ischaemic muscle
Holfeld, J., Gollmann‐Tepeköylü, C., Reißig, C., Lobenwein, D., Scheller, B., Kirchmair, E., Kozaryn, R., Albrecht-Schgoer, K., Krapf, C., Zins, K., et al. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv272 · Cited by 77
Viral and Synthetic RNA Vector Technologies and Applications
Schott, J. W., Morgan, M., Galla, M., & Schambach, A. (2016) · Molecular Therapy · doi:10.1038/mt.2016.143 · Cited by 76
Prophylactic and therapeutic implications of toll-like receptor ligands
Hedayat, M., Takeda, K., & Rezaei, N. (2012) · Medicinal Research Reviews · doi:10.1002/med.20214 · Cited by 76
THIS ARTICLE HAS BEEN RETRACTED: Toll‐like receptor 3 contributes to spinal glial activation and tactile allodynia after nerve injury
Obata, K., Katsura, H., Miyoshi, K., Kondo, T., Yamanaka, H., Kobayashi, K., Dai, Y., Fukuoka, T., Akira, S., & Noguchi, K. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05353.x · Cited by 80
Retracted
Melatonin decreases TLR3‐mediated inflammatory factor expression via inhibition of NF‐κB activation in respiratory syncytial virus‐infected RAW264.7 macrophages
Huang, S., Cao, X., & Wei, W. (2008) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2008.00560.x · Cited by 76
Concise Review: Application of In Vitro Transcribed Messenger RNA for Cellular Engineering and Reprogramming: Progress and Challenges
Steinle, H., Behring, A., Schlensak, C., Wendel, H. P., & Avci‐Adali, M. (2016) · Stem Cells · doi:10.1002/stem.2402 · Cited by 78
Regulation of autoimmune encephalomyelitis by toll-like receptors.
Marta, M., Meier, U., & Lobell, A. (2009) · Autoimmunity Reviews · doi:10.1016/j.autrev.2009.01.006 · Cited by 81
Beyond dsRNA: Toll-like receptor 3 signalling in RNA-induced immune responses
Tatematsu, M., Seya, T., & Matsumoto, M. (2014) · Biochemical Journal · doi:10.1042/bj20131492 · Cited by 77
Endogenous signals initiating inflammation in the injured nervous system
Pineau, I., & Lacroix, S. (2008) · Glia · doi:10.1002/glia.20763 · Cited by 78
Innate immune responses against mRNA vaccine promote cellular immunity through IFN-β at the injection site
Kim, S., Jeon, J. H., Kim, M., Lee, Y., Hwang, Y.-H., Park, M., Li, C. H., Lee, T., Lee, J.-A., Kim, Y., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51411-9 · Cited by 78
Toll-like receptor 3 plays a role in myocardial infarction and ischemia/reperfusion injury
Chen, L., Ren, D., Wang, X., Ha, T., Liu, L., Lee, E. J., Hu, J., Kalbfleisch, J. H., Gao, X., Kao, R. L., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.10.006 · Cited by 74
Expression of CCL20 and Its Corresponding Receptor CCR6 Is Enhanced in Active Inflammatory Bowel Disease, and TLR3 Mediates CCL20 Expression in Colonic Epithelial Cells
Skovdahl, H. K., Granlund, A. V. B., Østvik, A. E., Bruland, T., Bakke, I., TORP, S. H., Damås, J. K., & Sandvik, A. K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141710 · Cited by 75
A literature review for the mechanisms of stress‐induced liver injury
Joung, J., Cho, J.-H., Kim, Y., Choi, S., & Son, C. (2019) · Brain and Behavior · doi:10.1002/brb3.1235 · Cited by 77
Sensing Necrotic Cells
Miyake, Y., & Yamasaki, S. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-1680-7_9 · Cited by 78
Epilepsy and innate immune system: A possible immunogenic predisposition and related therapeutic implications
Matin, N., Tabatabaie, O., Falsaperla, R., Lubrano, R., Pavone, P., Mahmood, F., Gullotta, M., Serra, A., Mauro, P. D., Cocuzza, S. G., et al. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1034921 · Cited by 73
Dendritic Cell-Based Cancer Gene Therapy
Smits, E., Anguille, S., Cools, N., Berneman, Z. N., & Tendeloo, V. F. V. (2009) · Human Gene Therapy · doi:10.1089/hum.2009.145 · Cited by 75
Immunopathology of lupus nephritis
Anders, H., & Fogo, A. B. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-013-0413-5 · Cited by 73
Improved translation efficiency of therapeutic mRNA
Zarghampoor, F., Azarpira, N., Khatami, S. R., Behzad-Behbahani, A., & Foroughmand, A. M. (2019) · Gene · doi:10.1016/j.gene.2019.05.008 · Cited by 72
Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyond
Vallazza, B., Petri, S., Poleganov, M. A., Eberle, F., Kuhn, A. N., & Şahin, U. (2015) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1288 · Cited by 74
TLR3-Dependent Induction of Nitric Oxide Synthase in RAW 264.7 Macrophage-Like Cells via a Cytosolic Phospholipase A2/Cyclooxygenase-2 Pathway
Pindado, J., Balsinde, J., & Balboa, M. A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.7.4821 · Cited by 71
From regulation of dying cell engulfment to development of anti-cancer therapy
Krysko, D. V., & Vandenabeele, P. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402271 · Cited by 71
Effect of Toll‐Like Receptor (TLR) Agonists on TLR and Microbicide Expression in Uterine and Vaginal Tissues of the Mouse
Hussey, G. S., Schaefer, T. M., & Wira, C. R. (2006) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2006.00381.x · Cited by 71
Frequency and Associations of Adverse Reactions of COVID-19 Vaccines Reported to Pharmacovigilance Systems in the European Union and the United States
Montano, D. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2021.756633 · Cited by 70
Toll‐like receptors: The role in bladder cancer development, progression and immunotherapy
Moghadam, S. O., & Nowroozi, M. R. (2019) · Scandinavian Journal of Immunology · doi:10.1111/sji.12818 · Cited by 70
Toll-Like Receptor 3 Activation Is Required for Normal Skin Barrier Repair Following UV Damage
Borkowski, A. W., Kuo, I., Bernard, J. J., Yoshida, T., Williams, M. R., Hung, N., Yu, B., Beck, L. A., & Gallo, R. L. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.354 · Cited by 71
Cleaved/Associated TLR3 Represents the Primary Form of the Signaling Receptor
Toscano, F., Estornes, Y., Virard, F., Garcia-Cattaneo, A., Pierrot, A., Vanbervliet, B., Bonnin, M., Ciancanelli, M. J., Zhang, S., Funami, K., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1202173 · Cited by 70
Toll-like receptors. I. Structure, function and their ligands.
Sandor, F., & Buc, M. (2005) · Folia biologica · doi:10.14712/fb2005051050148 · Cited by 75
Expression of human GITRL on myeloid dendritic cells enhances their immunostimulatory function but does not abrogate the suppressive effect of CD4+CD25+ regulatory T cells
Tuyaerts, S., Meirvenne, S. V., Bonehill, A., Heirman, C., Corthals, J., Waldmann, H., Breckpot, K., Thielemans, K., & Aerts, J. L. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0906568 · Cited by 70
Adrenergic inhibition of innate anti-viral response: PKA blockade of Type I interferon gene transcription mediates catecholamine support for HIV-1 replication
Collado-Hidalgo, A., Sung, C., & Cole, S. (2006) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2006.01.005 · Cited by 69
The toll-like receptor-nuclear factor kB pathway in rheumatoid arthritis
Andreakos, E. (2005) · Frontiers in bioscience · doi:10.2741/1712 · Cited by 69
Do Cell-Penetrating Peptides Actually “Penetrate” Cellular Membranes?
Palm‐Apergi, C., Lönn, P., & Dowdy, S. F. (2012) · Molecular Therapy · doi:10.1038/mt.2012.40 · Cited by 73
Apoptotic Cells at the Crossroads of Tolerance and Immunity
Škoberne, M., Beignon, A., Larsson, M., & Bhardwaj, N. (2005) · Springer eBooks · doi:10.1007/3-540-27320-4_12 · Cited by 69
Danger in the Intensive Care Unit
Timmermans, K., Kox, M., Scheffer, G. J., & Pickkers, P. (2015) · Shock · doi:10.1097/shk.0000000000000506 · Cited by 70
Toll-like receptors 7 and 8 expression is associated with poor outcome and greater inflammatory response in acute ischemic stroke
Brea, D., Sobrino, T., Rodríguez‐Yáñez, M., Ramos‐Cabrer, P., Agulla, J., Rodríguez‐González, R., Campos, F., Blanco, M., & Castillo, J. (2011) · Clinical Immunology · doi:10.1016/j.clim.2011.02.001 · Cited by 67
Increased expression of Toll-like receptors 2 and 4 is associated with poor outcome in intracerebral hemorrhage
Rodríguez‐Yáñez, M., Brea, D., Arias, S., Blanco, M., Pumar, J. M., Castillo, J., & Sobrino, T. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.03.019 · Cited by 66
DAMP signaling in fungal infections and diseases
Cunha, C., Carvalho, A., Esposito, A., Bistoni, F., & Romani, L. R. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00286 · Cited by 69
Toll‐like receptor 3 polymorphism and its association with hepatitis B virus infection in Saudi Arabian patients
Al-Qahtani, A. A., Al‐Ahdal, M. N., Abdo, A. A., Sanai, F. M., Al‐Anazi, M. R., Khalaf, N. Z., Viswan, N. A., Al-Ashgar, H. I., Alhumaidan, H., Al‐Suwayeh, R., et al. (2012) · Journal of Medical Virology · doi:10.1002/jmv.23271 · Cited by 66
Surface Toll-like receptor 3 expression in metastatic intestinal epithelial cells induces inflammatory cytokine production and promotes invasiveness
Bugge, M., Bergstrøm, B., Eide, O. K., Solli, H., Kjønstad, I. F., Stenvik, J., Espevik, T., & Nilsen, N. J. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.784090 · Cited by 66
Toll-like Receptor 3 Is Required for Development of Retinopathy Caused by Impaired All-trans-retinal Clearance in Mice
Shiose, S., Chen, Y., Okano, K., Roy, S., Kohno, H., Tang, J. C. O., Pearlman, E. M., Maeda, T., Palczewski, K., & Maeda, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.228551 · Cited by 66
Signaling through MyD88 Regulates Leukocyte Recruitment after Brain Injury
Babcock, A. A., Toft‐Hansen, H., & Owens, T. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.6481 · Cited by 65
Toll-like Receptor 3 Is a Therapeutic Target for Pulmonary Hypertension
Farkas, D., Thompson, A. A. R., Bhagwani, A. R., Hultman, S., Ji, H., Kotha, N. C. R., Farr, G., Arnold, N. D., Braithwaite, A. T., Casbolt, H. L., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201707-1370oc · Cited by 64
The immune-inflammatory response of oligodendrocytes in a murine model of preterm white matter injury: the role of TLR3 activation
Boccazzi, M., Steenwinckel, J. V., Schang, A., Faivre, V., Charpentier, T. L., Bokobza, C., Csaba, Z., Verderio, C., Fumagalli, M., Mani, S., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03446-9 · Cited by 69
Toll-like receptor 3 signaling evokes a proinflammatory and proliferative phenotype in human vascular smooth muscle cells
Yang, X. T., Murthy, V., Schultz, K., Tatro, J. B., Fitzgerald, K. A., & Beasley, D. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00252.2006 · Cited by 63
Acute Neurodegeneration and the Inflammasome: Central Processor for Danger Signals and the Inflammatory Response?
Trendelenburg, G. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600609 · Cited by 64
Immunomodulatory Effects of dsRNA and Its Potential as Vaccine Adjuvant
Jin, B., Sun, T., Yu, X., Liu, C.-Q., Yang, Y.-X., Lu, P., Fu, S.-F., Hui-Bin, Q., & Yeo, A. E. T. (2010) · BioMed Research International · doi:10.1155/2010/690438 · Cited by 66
Microglial Toll-like Receptor 2 Contributes to Kainic Acid-induced Glial Activation and Hippocampal Neuronal Cell Death
Hong, J., Cho, I., Kwak, K. I., Suh, E. C., Seo, J., Min, H. J., Choi, S., Kim, C., Park, S. H., Jo, E., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.132522 · Cited by 64
TLR3, TRIF and Caspase 8 determine double-stranded RNA-induced epithelial cell death and survival in vivo
McAllister, C. S., Lakhdari, O., de Chambrun, G. D., Gareau, M., Broquet, A., Lee, G., Shenouda, S., Eckmann, L., & Kagnoff, M. (2012) · Journal of Immunology · doi:10.4049/jimmunol.1202756 · Cited by 65
Cardiac RNA Induces Inflammatory Responses in Cardiomyocytes and Immune Cells via Toll-like Receptor 7 Signaling
Feng, Y., Chen, H., Cai, J., Zou, L., Yan, D., Xu, G., Li, D., & Chao, W. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.661835 · Cited by 64
Synthetic Chemically Modified mRNA (modRNA): Toward a New Technology Platform for Cardiovascular Biology and MedicinePreprint
Chien, K. R., Zangi, L., & Lui, K. O. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014035 · Cited by 64
Targeting danger-associated molecular patterns after myocardial infarction
van Hout, G. P. J., Arslan, F., Pasterkamp, G., & Hoefer, I. E. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1088005 · Cited by 67
Interplay between Inflammation and Stemness in Cancer Cells: The Role of Toll-Like Receptor Signaling
Yeh, D., Huang, L.-R., Chen, Y., Huang, C. F., & Chuang, T. (2016) · Journal of Immunology Research · doi:10.1155/2016/4368101 · Cited by 63
Immunogenicity of necrotic cell death
Gamrekelashvili, J., Greten, T. F., & Korangy, F. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1741-x · Cited by 63
N1-methylpseudouridine found within COVID-19 mRNA vaccines produces faithful protein products
Kim, K. Q., Burgute, B. D., Tzeng, S., Jing, C., Jungers, C. F., Zhang, J., Yan, L. L., Vierstra, R. D., Djuranović, S., Evans, B. S., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111300 · Cited by 69
Dissecting TLR3 signalling in dendritic cells
Gauzzi, M. C., Cornò, M. D., & Gessani, S. (2010) · Immunobiology · doi:10.1016/j.imbio.2010.05.008 · Cited by 62
Antimicrobial Peptides and Complement in Neonatal Hypoxia-Ischemia Induced Brain Damage
Rocha‐Ferreira, E., & Hristova, M. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00056 · Cited by 63
Candida albicans Triggers Activation of Distinct Signaling Pathways to Establish a Proinflammatory Gene Expression Program in Primary Human Endothelial Cells
Müller, V. A., Viemann, D., Schmidt, M., Endres, N., Ludwig, S., Leverkus, M., Roth, J., & Goebeler, M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.12.8435 · Cited by 60
The impact of nucleoside base modification in mRNA vaccine is influenced by the chemistry of its lipid nanoparticle delivery system
Bernard, M., Bazin, E., Petiot, N., Lemdani, K., Commandeur, S., Verdelet, C., Margot, S., Perkov, V., Ripoll, M., Garinot, M., et al. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.05.004 · Cited by 63
Toll-like receptors in atherosclerosis: a ‘Pandora's box’ of advances and controversies
Cole, J. E., Kassiteridi, C., & Monaco, C. G. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.09.008 · Cited by 61
The intricate interplay between RNA viruses and NF-κB
Schmitz, M. L., Kracht, M., & Saul, V. V. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.08.004 · Cited by 61
Bovine viral diarrhea viruses modulate toll-like receptors, cytokines and co-stimulatory molecules genes expression in bovine peripheral blood monocytes
Lee, S.-R., Pharr, G. T., Boyd, B. L., & Pinchuk, L. M. (2007) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2007.06.006 · Cited by 60
Toll-like receptor-targeted anti-tumor therapies: Advances and challenges
Yang, Y., Li, H., Fotopoulou, C., Cunnea, P., & Zhao, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1049340 · Cited by 61
Breaking the mold with RNA—a “RNAissance” of life science
Jones, C. H., Androsavich, J. R., So, N., Jenkins, M. P., MacCormack, D., Prigodich, A. E., Welch, V., True, J. M., & Dolsten, M. (2024) · npj Genomic Medicine · doi:10.1038/s41525-023-00387-4 · Cited by 70
Toll‐like receptor (TLR) 3 immune modulation by unformulated small interfering RNA or DNA and the role of CD14 (in TLR‐mediated effects)
Weber, C., Müller, C., Podszuweit, A., Montino, C., Vollmer, J., & Forsbach, A. (2012) · Immunology · doi:10.1111/j.1365-2567.2012.03559.x · Cited by 60
Toll-Like Receptors as Interferon-Regulated Genes and Their Role in Disease
Khoo, J. J., Forster, S. C., & Mansell, A. S. (2011) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0095 · Cited by 61
Dual Effect of Hepatic Macrophages on Liver Ischemia and Reperfusion Injury during Liver Transplantation
Lu, T., Yang, T., Zhong, C., Shen, C., Lin, W.-W., Gu, G., Xia, Q., & Xu, N. (2018) · Immune Network · doi:10.4110/in.2018.18.e24 · Cited by 61
mRNA
Lint, S. V., Heirman, C., Thielemans, K., & Breckpot, K. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.22661 · Cited by 59
Review: Current trends, challenges, and success stories in adjuvant research
Singleton, K. L., Joffe, A. R., & Leitner, W. W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1105655 · Cited by 59
Virologic and Immunologic Events in Hilar Lymph Nodes During Simian Immunodeficiency Virus Infection
Fallert, B. A., Poveda, S. L., Schaefer, T. M., Pfeifer, M. E., Sanghavi, S., Watkins, S. C., Murphey‐Corb, M., Tarwater, P. M., Kirschner, D. E., & Reinhart, T. A. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31815cea8b · Cited by 59
Toll‐like Receptors in Multiple Sclerosis Mouse Experimental Models
Marta, M. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04849.x · Cited by 62
Targeting Toll-Like Receptors in Sepsis: From Bench to Clinical Trials
Chen, F., Zou, L., Williams, B., & Chao, W. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0005 · Cited by 62
Current progress in the development of prophylactic and therapeutic vaccines
Li, T., Qian, C., Gu, Y., Zhang, J., Li, S., & Xia, N. (2022) · Science China Life Sciences · doi:10.1007/s11427-022-2230-4 · Cited by 59
Involvement of innate immunity in the pathogenesis of intestinal Behçet's disease
Nara, K., Kurokawa, M. S., Chiba, S., Yoshikawa, H., Tsukikawa, S., Matsuda, T., & Suzuki, N. (2008) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2008.03626.x · Cited by 58
TLR3 Ligand Induces NF-κB Activation and Various Fates of Multiple Myeloma Cells Depending on IFN-α Production
Chiron, D., Pellat‐Deceunynck, C., Amiot, M., Bataille, R., & Jégo, G. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803113 · Cited by 58
TLR3/TICAM-1 signaling in tumor cell RIP3-dependent necroptosis
Seya, T., Shime, H., Takaki, H., Azuma, M., Oshiumi, H., & Matsumoto, M. (2012) · OncoImmunology · doi:10.4161/onci.21244 · Cited by 58
The TLR3 ligand polyI:C downregulates connexin 43 expression and function in astrocytes by a mechanism involving the NF‐κB and PI3 kinase pathways
Zhao, Y.-M., Rivieccio, M. A., Lutz, S. E., Scemes, E., & Brosnan, C. (2006) · Glia · doi:10.1002/glia.20418 · Cited by 61
TLR3 plays significant roles against hepatitis B virus
Karimi‐Googheri, M., & Arababadi, M. K. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3190-x · Cited by 57
TLR3-mediated NF-κB signaling in human esophageal epithelial cells
Lim, D. M., Narasimhan, S., Michaylira, C. Z., & Wang, M. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00065.2009 · Cited by 57
2′Fluoro Modification Differentially Modulates the Ability of RNAs to Activate Pattern Recognition Receptors
Lee, Y.-J., Urban, J. H., Xu, L., Sullenger, B. A., & Lee, J. (2016) · Nucleic Acid Therapeutics · doi:10.1089/nat.2015.0575 · Cited by 58
Design, Assembly, Production, and Transfection of Synthetic Modified mRNA
Oh, S., & Kessler, J. A. (2018) · Methods · doi:10.1016/j.ymeth.2017.10.008 · Cited by 58
A Review of Human Coronaviruses’ Receptors: The Host-Cell Targets for the Crown Bearing Viruses
Nassar, A. M., Ibrahim, I. M., Amin, F. G., Magdy, M., Elgharib, A. M., Azzam, E. B., Nasser, F., Yousry, K., Shamkh, I. M., Mahdy, S. M., et al. (2021) · Molecules · doi:10.3390/molecules26216455 · Cited by 59
Expression of Toll-like receptor-3 is enhanced in active inflammatory bowel disease and mediates the excessive release of lipocalin 2
Østvik, A. E., Granlund, A. V. B., TORP, S. H., Flatberg, A., Beisvåg, V., Waldum, H. L., Flo, T. H., Espevik, T., Damås, J. K., & Sandvik, A. K. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12136 · Cited by 56
Differential MSC activation leads to distinct mononuclear leukocyte binding mechanisms
Kota, D. J., DiCarlo, B., Hetz, R. A., Smith, P., Cox, C. S., & Olson, S. D. (2014) · Scientific Reports · doi:10.1038/srep04565 · Cited by 56
Toll-like receptors in kidney disease
Smith, K. D. (2009) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32832a1d5f · Cited by 54
Expression of Toll-Like Receptors (TLR) and Responsiveness to TLR Agonists by Polarized Mouse Uterine Epithelial Cells in Culture1
Hussey, G. S., Shen, L., & Wira, C. R. (2006) · Biology of Reproduction · doi:10.1095/biolreprod.106.050690 · Cited by 56

Authors: Karikó, K., Ni, H., Capodici, J., Lamphier, M., & Weissman, D.
Affiliations: University of Pennsylvania (US)
Eisai (United States) (US)
Corresponding author: Karikó, Katalin
ORCID: Karikó, Katalin
Ni, Houping
Weissman, Drew
Venue: Journal of Biological Chemistry
Publisher: Elsevier BV
Published: 2004-03
Volume: 279
Issue: 13
Pages: 12542-12550
ISSN: 0021-9258 (ISSN-L)
DOI: 10.1074/jbc.m310175200
OpenAlex: W1986178107
Cited by: 1,062
References: 63
Citations by year: 2026: 19 · 2025: 41 · 2024: 39 · 2023: 64 · 2022: 48 · 2021: 55 · 2020: 37 · 2019: 32 · 2018: 41 · 2017: 51 · 2016: 38 · 2015: 46 · 2014: 46 · 2013: 57 · 2012: 67
FWCI: 19.76
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by/4.0/ (vor, 6057 d)
Locations: Journal of Biological Chemistry (publishedVersion, cc-by)
PubMed (publishedVersion)
Funders: National Institutes of Health (5r01hl062060-05)
National Heart, Lung, and Blood Institute (HL62060-04)
National Institute of Allergy and Infectious Diseases (AI-50484, R01AI050484)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
Keywords: TLR3, mRNA, endogenous ligands, innate immunity, dendritic cell maturation, necrotic cells, double-stranded RNA, interferon-alpha, NF-κB, tyrosine phosphorylation, IRF1, TNF-α, RNA secondary structure
MeSH terms: Cell Line, Dendritic Cells, Dose-Response Relationship, Drug, Enzyme Inhibitors, Enzyme-Linked Immunosorbent Assay, Humans, Ligands, Luciferases, Membrane Glycoproteins, Necrosis, Nucleic Acid Conformation, Plasmids, Protein Kinases, Receptors, Cell Surface, RNA, RNA, Double-Stranded, RNA, Messenger, Transcription, Genetic, Transfection, Tumor Necrosis Factor-alpha, Tyrosine, Blotting, Northern, Signal Transduction, Up-Regulation, Interleukin-8, NF-kappa B, Staurosporine, Genistein, Toll-Like Receptors, Toll-Like Receptor 3, Interleukin-1 Receptor-Associated Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

mRNA Is an Endogenous Ligand for Toll-like Receptor 3

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks